Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
4,002,762
-
Share change
-
-120,837
-
Total reported value
-
$172,249,892
-
Price per share
-
$43.03
-
Number of holders
-
77
-
Value change
-
-$5,007,669
-
Number of buys
-
34
-
Number of sells
-
35
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2017
As of 30 Jun 2017,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,002,762 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, Psagot Investment House Ltd., UBS Group AG, Wharton Business Group, LLC, Baird Financial Group, Inc., BNP PARIBAS ARBITRAGE, SA, IFP Advisors, Inc, and Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.